Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis

被引:20
|
作者
Rhindress, K. [1 ]
Robinson, D. G. [2 ,3 ,4 ]
Gallego, J. A. [5 ]
Wellington, R. [6 ]
Malhotra, A. K. [2 ,3 ,4 ]
Szeszko, P. R. [7 ,8 ]
机构
[1] NYU, Sch Med, Dept Psychiat, New York, NY USA
[2] Hofstra Northwell Sch Med, Dept Psychiat, Hempstead, NY USA
[3] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA
[4] North Shore LIJ Hlth Syst, Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA
[5] Weill Cornell Med Coll, Dept Psychiat, White Plains, NY USA
[6] St Johns Univ, Dept Psychol, Queens, NY USA
[7] James J Peters VA Med Ctr, Bronx, NY USA
[8] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
关键词
Antipsychotic treatment; dendate gyrus; hippocampus; psychosis; subiculum; MAGNETIC-RESONANCE IMAGES; HIGH-RESOLUTION MRI; LONG-TERM TREATMENT; ALZHEIMERS-DISEASE; AUTOMATIC SEGMENTATION; RECEPTOR ACTIVATION; ATROPHY PATTERNS; DENTATE GYRUS; GRAY-MATTER; SCHIZOPHRENIA;
D O I
10.1017/S0033291717000137
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Hippocampal dysfunction is considered central to many neurobiological models of schizophrenia, yet there are few longitudinal in vivo neuroimaging studies that have investigated the relationship between antipsychotic treatment and morphologic changes within specific hippocampal subregions among patients with psychosis. Method. A total of 29 patients experiencing a first episode of psychosis with little or no prior antipsychotic exposure received structural neuroimaging examinations at illness onset and then following 12 weeks of treatment with either risperidone or aripiprazole in a double-blind randomized clinical trial. In addition, 29 healthy volunteers received structural neuroimaging examinations at baseline and 12-week time points. We manually delineated six hippocampal subregions [i.e. anterior cornu ammonis (CA) 1-3, posterior CA1-3, subiculum, dentate gyrus/CA4, entorhinal cortex, and fimbria] from 3T magnetic resonance images using an established method with high inter- and intra-rater reliability. Results. Following antipsychotic treatment patients demonstrated significant reductions in dentate gyrus/CA4 volume and increases in subiculum volume. Healthy volunteers demonstrated non-significant volumetric changes in these subregions across the two time points. We observed a significant quadratic (i.e. inverted U) association between changes in dentate gyrus/CA4 volume and cumulative antipsychotic dosage between the scans. Conclusions. This study provides the first evidence to our knowledge regarding longitudinal in vivo volumetric changes within specific hippocampal subregions in patients with psychosis following antipsychotic treatment. The finding of a non-linear relationship between changes in dentate gyrus/CA4 subregion volume and antipsychotic exposure may provide new avenues into understanding dosing strategies for therapeutic interventions relevant to neurobiological models of hippocampal dysfunction in psychosis.
引用
收藏
页码:1706 / 1718
页数:13
相关论文
共 50 条
  • [31] Treatment Principles of First-Episode Psychosis
    Ucok, Alp
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2021, 58 : S12 - S16
  • [32] The evaluation and treatment of first-episode psychosis
    Sheitman, BB
    Lee, H
    Strauss, R
    Lieberman, JA
    SCHIZOPHRENIA BULLETIN, 1997, 23 (04) : 653 - 661
  • [33] Hippocampal Subfield Volumes in Patients With First-Episode Psychosis
    Baglivo, Valentina
    Cao, Bo
    Mwangi, Benson
    Bellani, Marcella
    Perlini, Cinzia
    Lasalvia, Antonio
    Dusi, Nicola
    Bonetto, Chiara
    Cristofalo, Doriana
    Alessandrini, Franco
    Zoccatelli, Giada
    Ciceri, Elisa
    Dario, Lamonaca
    Enrico, Ceccato
    Francesca, Pileggi
    Mazzi, Fausto
    Paolo, Santonastaso
    Balestrieri, Matteo
    Soares, Jair C.
    Ruggeri, Mirella
    Brambilla, Paolo
    SCHIZOPHRENIA BULLETIN, 2018, 44 (03) : 552 - 559
  • [34] Antipsychotic drug effects on brain morphology in first-episode psychosis
    Lieberman, JA
    Tollefson, GD
    Charles, C
    Zipursky, R
    Sharma, TN
    Kahn, RS
    Keefe, RSE
    Green, AI
    Gur, RE
    McEvoy, J
    Perkins, D
    Hamer, RM
    Gu, HB
    Tohen, M
    ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (04) : 361 - 370
  • [35] Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis
    Rabinovitch, Mark
    Bechard-Evans, Laura
    Schmitz, Norbert
    Joober, Ridha
    Malla, Ashok
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2009, 54 (01): : 28 - 35
  • [36] Should antipsychotic medication always be given for first-episode psychosis?
    Francey, Shona M.
    Nelson, Barnaby
    Harrigan, Susy
    Kerr, Melissa
    Spiliotacopoulos, Daniela
    Macneil, Craig
    Crisp, Kingsley
    Hughes, Frank
    Thompson, Andrew
    Bechdolf, Andreas
    Berk, Michael
    McGorry, Patrick D.
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 96 - 96
  • [37] Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
    Riecher-Roessler, A.
    Rybakowski, J. K.
    Pflueger, M. O.
    Beyrau, R.
    Kahn, R. S.
    Malik, P.
    Fleischhacker, W. W.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (12) : 2571 - 2582
  • [38] Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
    Ballesteros, Alejandro
    Sanchez-Torres, Ana M.
    Lopez-Ilundain, Jose M.
    Cabrera, Bibiana
    Lobo, Antonio
    Gonzalez-Pinto, Ana M.
    Diaz-Caneja, Covadonga
    Corripio, Iluminada
    Vieta, Eduard
    de la Serna, Elena
    Bobes, Julio
    Usall, Judith
    Contreras, Fernando
    Lorente-Omenaca, Ruth
    Mezquida, Gisela
    Bernardo, Miguel
    Cuesta, Manuel J.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (13) : 2247 - 2256
  • [39] Brain volume change in first-episode psychosis: an effect of antipsychotic medication independent of BMI change
    Jorgensen, K. N.
    Nesvag, R.
    Nerland, S.
    Morch-Johnsen, L.
    Westlye, L. T.
    Lange, E. H.
    Haukvik, U. K.
    Hartberg, C. B.
    Melle, I.
    Andreassen, O. A.
    Agartz, I.
    ACTA PSYCHIATRICA SCANDINAVICA, 2017, 135 (02) : 117 - 126
  • [40] STUDYING THE BIOLOGICAL PATHWAYS FROM STRESS TO PSYCHOSIS AND HOW THEY ARE INFLUENCED BY ANTIPSYCHOTIC TREATMENT IN FIRST-EPISODE PSYCHOSIS
    Mondelli, V.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 : A86 - A86